pharma · Hemophilia · Gaucher's disease type I; Gaucher's disease type III
Genzyme Europe
Genzyme Europe B.V.
Genzyme Europe patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
NL HQ
1981 Founded
273 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- NL
- Founded
- 1981
- Employees
- 273
- Programs
- 5
- Drugs
- 10
- Patents
- 0
Genzyme Europe patents
0 pharmaceutical patents indexed for Genzyme Europe. 0 expire within 24 months.
Genzyme Europe has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Genzyme Europe have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Genzyme Europe patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.